Biotech | November 03, 2021
Lonza to acquire Exosomics service unit in Italy
Expertise in exosomes isolation and characterization will drive innovation in this field
Expertise in exosomes isolation and characterization will drive innovation in this field
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Clear aligners are a series of tight-fitting custom-made mouthpieces or orthodontic systems that are useful in correcting misaligned or crooked teeth
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
The collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings
Subscribe To Our Newsletter & Stay Updated
